Neuropilin-1 (NRP-1) and magnetic nanoparticles, a potential combination for diagnosis and therapy of gliomas

Lukui Chen, Guilong Zhang, Yan Shi, Rong Qiu, Ahsan Ali Khan

Research output: Contribution to journalReview articlepeer-review

22 Citations (Scopus)

Abstract

In this review, Neuropilin-1 (NRP-1) has been focused as a novel molecular target for potential treatment of gliomas. The properties of NRP-1 were described briefly. The role of NRP-1 in gliomas was explored in details, including relationships of NRP-1 expression and glioma prognosis, Sema3A-NRP-1 signaling in gliomas, NRP-1 signaling and VEGF/VEGFR, PlGF, TGF-β, PDGF, LD22-4 of FGF2, autocrine of HGF/SF, p130Cas tyrosine phosphorylation and integrin-associated tumor microenvironment in gliomas, NRP-1 intracellular trafficking, NRP-1 and glioma stem-like cells, as well as magnetic nanoparticles related to targeting gliomas. NRP-1, a multifunctional- receptors protein, would mediate diverse cellular signaling pathways in gliomas, and might potentially act as a novel therapeutic target. In future, magnetic nanoparticles coated with NRP-1 may play a vital role on diagnosis and therapy of gliomas.

Original languageEnglish (UK)
Pages (from-to)5434-5449
Number of pages16
JournalCurrent Pharmaceutical Design
Volume21
Issue number37
DOIs
Publication statusPublished - 1 Oct 2015
Externally publishedYes

Keywords

  • Gene therapy
  • Glioma
  • Glioma stem cell
  • Magnetic nanoparticle
  • Neuropilin-1
  • Trafficking

Fingerprint

Dive into the research topics of 'Neuropilin-1 (NRP-1) and magnetic nanoparticles, a potential combination for diagnosis and therapy of gliomas'. Together they form a unique fingerprint.

Cite this